HAL vs HCAT · P/E 9.3, $19.05B cap vs rev $306.6M
Halliburton Company (HAL) versus Health Catalyst Inc (HCAT) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Health Catalyst Inc (HCAT) is a health information services company listed on NASDAQ.
HAL does not have a complete income-statement cache yet.
Latest reported HCAT revenue for 2024-12-31 was $306.6M. Net income was -$69.5M. Revenue was up 3.6% from 2023-12-31 to 2024-12-31. HCAT currently screens at market cap $130.8M.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. HCAT currently screens at market cap $130.8M.
Not investment advice. Open the HAL and HCAT stock pages for the full models.
Not investment advice.